The two faces of IL-6 on Th1/Th2 differentiation.

[1]  E. Serfling,et al.  Induction of NFATc2 Expression by Interleukin 6 Promotes T Helper Type 2 Differentiation , 2002, The Journal of experimental medicine.

[2]  W. Alexander,et al.  Neutralization of interferon‐γ in neonatal SOCS1−/− mice prevents fatty degeneration of the liver but not subsequent fatal inflammatory disease , 2001, Immunology.

[3]  H. Okamura,et al.  Interleukin-18 regulates both Th1 and Th2 responses. , 2001, Annual review of immunology.

[4]  E. Fikrig,et al.  Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. , 2000, Immunity.

[5]  W. Ouyang,et al.  Signaling and transcription in T helper development. , 2000, Annual review of immunology.

[6]  T. Naka,et al.  Negative regulation of cytokine signaling: STAT-induced STAT inhibitor. , 1999, Trends in biochemical sciences.

[7]  W. Alexander,et al.  Suppressors of cytokine signaling (SOCS): negative regulators of signal transduction , 1999, Journal of leukocyte biology.

[8]  A. Yoshimura,et al.  SOCS1 Deficiency Causes a Lymphocyte-Dependent Perinatal Lethality , 1999, Cell.

[9]  Paul J Hertzog,et al.  SOCS1 Is a Critical Inhibitor of Interferon γ Signaling and Prevents the Potentially Fatal Neonatal Actions of this Cytokine , 1999, Cell.

[10]  Roger J. Davis,et al.  Requirement for Transcription Factor NFAT in Interleukin-2 Expression , 1999, Molecular and Cellular Biology.

[11]  Y. Uchiyama,et al.  Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Elefanty,et al.  Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Valeria Poli,et al.  The Role of C/EBP Isoforms in the Control of Inflammatory and Native Immunity Functions* , 1998, The Journal of Biological Chemistry.

[14]  E. Fikrig,et al.  Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased lyme arthritis. , 1998, The Journal of infectious diseases.

[15]  A. O’Garra,et al.  Cytokines induce the development of functionally heterogeneous T helper cell subsets. , 1998, Immunity.

[16]  T. Hirano.  Interleukin 6 and its receptor: ten years later. , 1998, International reviews of immunology.

[17]  W. Leonard,et al.  Jaks and STATs: biological implications. , 1998, Annual review of immunology.

[18]  S. Akira,et al.  Structure and function of a new STAT-induced STAT inhibitor , 1997, Nature.

[19]  Takaho A. Endo,et al.  A new protein containing an SH2 domain that inhibits JAK kinases , 1997, Nature.

[20]  Warren S. Alexander,et al.  A family of cytokine-inducible inhibitors of signalling , 1997, Nature.

[21]  E. Fikrig,et al.  Interleukin (IL)-6 Directs the Differentiation of IL-4–producing CD4+ T Cells , 1997, The Journal of experimental medicine.

[22]  S. Constant,et al.  Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. , 1997, Annual review of immunology.

[23]  M Aguet,et al.  The IFN gamma receptor: a paradigm for cytokine receptor signaling. , 1997, Annual review of immunology.

[24]  M. Croft,et al.  A direct role for IFN-gamma in regulation of Th1 cell development. , 1996, Journal of immunology.

[25]  E. Fikrig,et al.  Effect of anti-interleukin 12 treatment on murine lyme borreliosis. , 1996, The Journal of clinical investigation.

[26]  A. Keane-Myers,et al.  Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice. , 1995, Journal of immunology.

[27]  S. Swain.  T-Cell Subsets: Who does the polarizing? , 1995, Current Biology.

[28]  T. Hirano,et al.  Signal Transduction through IL‐6 Receptor: Involvement of Multiple Protein Kinases, Stat Factors, and a Novel H7‐sensitive Pathway a , 1995, Annals of the New York Academy of Sciences.

[29]  S. Reiner,et al.  T helper phenotype and genetic susceptibility in experimental Lyme disease , 1995, The Journal of experimental medicine.

[30]  S. Akira,et al.  Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway , 1994, Cell.

[31]  G. Yancopoulos,et al.  Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. , 1994, Science.

[32]  C. Schindler,et al.  Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. , 1994, Science.

[33]  A. Sher,et al.  Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. Nel,et al.  Recombinant IL-6 activates p42 and p44 mitogen-activated protein kinases in the IL-6 responsive B cell line, AF-10. , 1993, Journal of immunology.

[35]  C. Hsieh,et al.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.

[36]  R. Cortese,et al.  The two C/EBP isoforms, IL6DBP/NFIL6 and CEBP6δ/NFIL63, are induced by IL6β to promote acute phase gene transcription via different mechanisms , 1993 .

[37]  W. Paul,et al.  The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice , 1992, The Journal of experimental medicine.

[38]  S. Akira,et al.  A member of the C/EBP family, NF-IL6 beta, forms a heterodimer and transcriptionally synergizes with NF-IL6. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[39]  A. Weinberg,et al.  IL-4 directs the development of Th2-like helper effectors. , 1990, Journal of immunology.

[40]  R. Cortese,et al.  IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C EBP , 1990, Cell.

[41]  W. Paul,et al.  Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4- producing cells , 1990, The Journal of experimental medicine.

[42]  S. Akira,et al.  A nuclear factor for IL‐6 expression (NF‐IL6) is a member of a C/EBP family. , 1990, The EMBO journal.

[43]  S. Jameson,et al.  Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor , 1989, Nature.

[44]  T. Hirano,et al.  Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130 , 1989, Cell.